BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Meditech Pharmaceuticals, Inc. (MDCH) Announces Publication Of Clinical Trial Results


10/19/2005 5:10:02 PM

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Feb. 17, 2004--Meditech Pharmaceuticals Inc. (OTC BB: MDCH - News) announced today that the results of the Cold Sore (HSV-1) clinical trials conducted at the Boston University Medical Center are being published today in the Journal of Medical Internet Research (www.jmir.org).

To prevent denial of publication for reasons of "pre-publication," and to preserve our rights under our pending patent application, the study results have been kept confidential pending publication.

Meditech is a drug development company focused on the development of human, veterinary and agricultural antimicrobial agents as well as its interest in a joint venture with Elan-Bio in their bio-terrorism scanner. Meditech was founded in 1982 as Medical Technology Corp. of America and went public via an IPO in 1983.

This press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are subject to risks and uncertainties that could cause actual results and events to differ materially. For a discussion of other risks that could cause actual results or events to differ materially from such forward-looking statements, see the discussion of ("Risks That Could Affect Our Financial Condition and Results of Operations") in Meditech's 10-KSB filing with the SEC for the year ended May 31, 2003. Meditech undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact:

Meditech Pharmaceuticals Inc., Scottsdale Cindy Kern, 480-614-2874 Fax: 480-614-0560 ir@mdch.net http://www.mdch.net

Source: Meditech Pharmaceuticals Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES